Insurers must cover injectable HIV prevention drug — unless courts void mandate

United States News News

Insurers must cover injectable HIV prevention drug — unless courts void mandate
United States Latest News,United States Headlines
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 67 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 86%

The federal judiciary could strip a health task force’s effective authority to require insurers cover preventive interventions, including the HIV PrEP drug Apretude.

advancing through the courts could void the requirement that insurers cover the HIV-prevention drug, along with dozens of other coverage mandates stemming from the task force’s recommendations. That could have a sweeping impact on people’s ability to afford preventive interventions and screenings for a host of health conditions.

. The paper states “with high certainty” that all three currently approved forms of PrEP provide a “substantial net benefit” to adults and adolescents at elevated risk of HIV.Rich Pedroncelli / AP file The endorsement concerns two daily oral medications, Gilead Sciences’ Truvada and Descovy, and ViiV Healthcare’s long-acting injectable medication, Apretude.that Apretude, which is provided every eight weeks by a health care worker, is superior to Truvada at preventing HIV across a population of at-risk people. But nearly two years after Apretude hit the market, its potential to combat HIV in the U.S. remains woefully unrealized; because of its high cost, insurers rarely cover it.

Dr. Kenneth Mayer, the medical research director at the Fenway Institute, an LGBTQ-focused clinic in Boston, characterized the task force’s Apretude recommendation as “gratifying.” However, he expressed frustration over the roadblocks prescribers such as him have faced when they seek to put patients on Apretude.

“Insurance hassles have definitely been part of the problem, including high copays and requirements that providers demonstrate that patients failed oral regimens,” said Mayer, who was the lead author of aThe task force granted Truvada, Descovy and Apretude “A” ratings for their use as HIV PrEP, as it

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCNews /  🏆 10. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Live blog: Ukraine nears deal with insurers to cover grain shipsLive blog: Ukraine nears deal with insurers to cover grain shipsRussia-Ukraine conflict rages on its 544th day.
Read more »

Hurricane Hilary PrepHurricane Hilary PrepLA officials provide update on emergency plans
Read more »

PPR Team Preview: Escondido -PPR Team Preview: Escondido -Categories: All Sports Report, Sports Tags: Escondido HS, high school sports, Prep Pigskin Report, sports
Read more »

The Best Apocalyptic Shows on Netflix Right NowThe Best Apocalyptic Shows on Netflix Right NowPrep for doomsday with these binge-worthy series.
Read more »

Haley says she's ready for first GOP debate, calls rallies 'the best debate prep'Haley says she's ready for first GOP debate, calls rallies 'the best debate prep'2024 Republican presidential candidate Nikki Haley said she is ready for the first Republican presidential debate, noting that the many rallies she attended in advance helped prepare her.
Read more »

Prep Rally: A high school football zero week recapPrep Rally: A high school football zero week recapZero Week in high school football produced some top individual performances but not a whole lot of upsets.
Read more »



Render Time: 2025-02-24 22:02:28